Cross cultural adaptation of patient reported outcomes (PRO)
OtherProcess used to adapt a questionnaire from one cultural setting to another
NCT Number: NCT02883322
Objectives: To identify the respective contributions of back-translations and of the expert committee in the process of cultural adaptation of patient reported outcome with an experimental design in the adaptation process :
Four translations of a questionnaire will be produced:
* A simple translation by two translators, who serves as the basis for the three other translations * A translation made with the use of a back-translation. * A translation with review by an expert committee. * A translation the use of a back-translation and review by an expert committee.
Properties of each translation will be analyzed and compared
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Process used to adapt a questionnaire from one cultural setting to another
Time frame: baseline
Face/content validity, reliability, structural validity
Looking for future studies?
Notify MeGUILLEMIN Francis, MD
Other
Acronym: APPROVALS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06993935
Arthritis, Arthritis, Rheumatoid
Yozgat, Turkey (Türkiye)
View Trial DetailsNCT04746859
Cancer, Chronic Disease
Barrie, Ontario, Canada
View Trial DetailsNCT07099365
Anxiety Disorders, Behavior
London, United Kingdom
View Trial DetailsNCT04815434
Adult, Chronic Disease
Clermont-Ferrand, AURA, France
View Trial Details